Antigens Predicted for Broad Viral Efficacy through Computational Experimentation (APECx)

The summary for the Antigens Predicted for Broad Viral Efficacy through Computational Experimentation (APECx) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Advanced Research Projects Agency for Health, which is the U.S. government agency offering this grant.

Antigens Predicted for Broad Viral Efficacy through Computational Experimentation (APECx): The Advanced Research Projects Agency for Health (ARPA-H) posts this funding opportunity in support of its Antigens Predicted for Broad Viral Efficacy through Computational Experimentation (APECx) Program. ARPA-H anticipates multiple awards and award types will result from this announcement.Interested parties are invited to review attached APECx Research & Development Solicitation No. 75N99224R00001. Abstracts are due December 15, 2023, 9:00 AM ET. Proposals will be invite-only and will be due February 16, 2024, 5:00 PM ET. An abstract must be submitted to be invited to submit a proposal.Please ensure to follow this opportunity for any updates.For more information about APECx, please visit https://arpa-h.gov/engage/programs/apecx/.Please note that the APEX Accelerators government contracting resource for small businesses notice is included on all SAM.gov postings and is unrelated to the ARPA-H APECx program.